Rekvina Laboratories

Sector: Healthcare

Followers

3
3
1
1
.
3
3
4
4
0.84 (1.99%)

As on 17 Apr, 2026 | 16:01

Open Trading A/c
Day Range
43.13
43.13
LH
52 Week Range
6.75
43.13
LH
Volume
* i
Bid / Ask
5,752.00
0.00 / 0.00

Rekvina Laboratories Announcements

Voting Results along with Scrutinizer Report

10 Apr, 2026 | 05:42pm • Source: BSE

Summary of Proceeding of EGM

10 Apr, 2026 | 05:11pm • Source: BSE

Non Applicability of Reg- 24(A) - Annual Secretarial Compliance Report

06 Apr, 2026 | 06:42pm • Source: BSE

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018.

06 Apr, 2026 | 05:37pm • Source: BSE

Update on Open Offer

02 Apr, 2026 | 06:30pm • Source: BSE

Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of...

02 Apr, 2026 | 06:20pm • Source: BSE

Update on Open Offer

24 Mar, 2026 | 06:31pm • Source: BSE

Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Detailed Public Statement for the attention of the...

24 Mar, 2026 | 02:23pm • Source: BSE

Trading window will remain closed with effect from, 1st April, 2026 until 48 hours after the declaration of Audited Financial Results by the Company for...

24 Mar, 2026 | 11:55am • Source: BSE

Shareholders Meeting - EGM 10.04.2026

18 Mar, 2026 | 02:11pm • Source: BSE

Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Public Announcement for the attention of the Public...

16 Mar, 2026 | 08:00pm • Source: BSE

The Company has approved Preferential Issue of Share through;1. Swap of Shares2. Cash Considerationas per attached details.

16 Mar, 2026 | 06:57pm • Source: BSE

The Board of Directors of the company has approved Increase in Authorized Capital of the company.

16 Mar, 2026 | 06:53pm • Source: BSE

Outcome of Board Meeting 16.03.2026

16 Mar, 2026 | 06:50pm • Source: BSE

Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulation, 2015 , we hereby inform you that the Board of...

09 Feb, 2026 | 01:27pm • Source: BSE

Dear Sir/Madam,Pursuant to Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulations, 2015, we hereby inform you that the...

06 Feb, 2026 | 05:55pm • Source: BSE

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 , please to informed that Mr. Chetanbhai Patel has tender his...

29 Jan, 2026 | 04:14pm • Source: BSE

Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation , 2015, we hereby inform you that the Board of Directors...

29 Jan, 2026 | 03:56pm • Source: BSE

Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and...

29 Jan, 2026 | 02:37pm • Source: BSE

Pursuant to Regulation 30 of Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that Mr. Dhruvalkumar Jayantilal Patel...

09 Jan, 2026 | 01:49pm • Source: BSE